Roivant Sciences Ltd. (ROIV) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$27.91
+0.22%
Mkt Cap $20.96B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 6, 2026 | $5.08M | $2.00M | -60.65% | -$0.30 | -$0.24 | +19.88% | — | — |
| Q4 2025 Nov 10, 2025 | $5.62M | $1.57M | -72.04% | -$0.32 | -$0.28 | +12.45% | — | — |
| Q3 2025 Aug 11, 2025 | $7.30M | $2.17M | -70.28% | -$0.25 | -$0.18 | +27.91% | — | — |
| Q2 2025 May 29, 2025 | $54.07M | $7.57M | -86.00% | -$0.26 | -$0.22 | +16.51% | — | — |
| Q1 2025 Feb 10, 2025 | $62.17M | $9.02M | -85.49% | -$0.24 | -$0.13 | +45.83% | — | — |
| Q4 2024 Nov 12, 2024 | $45.92M | $4.47M | -90.26% | -$0.25 | -$0.29 | -17.41% | — | — |
| Q3 2024 Aug 8, 2024 | $30.72M | $55.13M | +79.47% | -$0.24 | -$0.18 | +26.03% | — | — |
| Q2 2024 May 30, 2024 | $31.01M | $28.93M | -6.70% | -$0.26 | -$0.23 | +12.99% | — | — |
| Q1 2024 Feb 13, 2024 | $33.72M | $37.14M | +10.14% | -$0.27 | -$0.21 | +22.22% | — | — |
| Q4 2023 Nov 13, 2023 | $30.12M | $37.10M | +23.18% | -$0.28 | -$0.26 | +7.14% | — | — |
| Q3 2023 Aug 14, 2023 | $25.07M | $21.62M | -13.75% | -$0.26 | -$0.38 | -46.15% | — | — |
| Q2 2023 Jun 28, 2023 | $21.53M | $27.38M | +27.15% | -$0.41 | -$0.20 | +51.22% | — | — |
| Q1 2023 Feb 13, 2023 | $18.16M | $17.05M | -6.10% | -$0.36 | -$0.49 | -36.11% | — | — |
| Q4 2022 Nov 14, 2022 | $5.70M | $12.53M | +119.85% | -$0.41 | -$0.42 | -2.44% | — | — |
| Q3 2022 Aug 15, 2022 | $7.18M | $4.32M | -39.83% | -$0.30 | -$0.48 | -60.00% | — | — |
| Q2 2022 Jun 28, 2022 | $13.35M | $11.21M | -16.03% | -$0.25 | -$0.39 | -56.00% | — | — |
| Q1 2022 Feb 14, 2022 | $9.87M | $24.34M | +146.72% | -$0.23 | -$0.41 | -78.26% | — | — |
| Q4 2021 Nov 15, 2021 | — | $13.99M | — | -$0.45 | -$0.26 | +42.22% | — | — |